Key takeaways
- CBT-I (cognitive behavioral therapy for insomnia) is the guideline-recommended first-line treatment for chronic insomnia — not medication or sleep hygiene alone (ACP guideline; AASM behavioral guideline).
- A meta-analysis of 20 RCTs (1,162 participants) found multimodal CBT-I cut sleep-onset latency by ~19 minutes and wake-after-sleep-onset by ~26 minutes (Annals of Internal Medicine).
- Sleep hygiene alone is explicitly not recommended as a stand-alone treatment for chronic insomnia by AASM — it only works as a supporting foundation.
- 400 mg of caffeine still measurably disrupted sleep when taken a full 6 hours before bedtime in a controlled trial, supporting a 6-hour-minimum caffeine cutoff (Drake et al., J Clin Sleep Med).
- Melatonin is well-supported for jet lag and circadian phase-shifting (Cochrane), but AASM specifically advises against using it for routine adult insomnia.
The best-supported way to prevent and manage persistent sleep problems is a layered plan: protect a regular sleep-wake schedule, use light and activity to anchor the circadian clock, remove sleep-disrupting inputs such as late caffeine, and use cognitive behavioral therapy for insomnia (CBT-I) when insomnia becomes chronic. CBT-I is the first-line treatment for chronic insomnia in major guidelines, while melatonin is strongest for jet lag or circadian phase-shift problems rather than routine adult insomnia (ACP guideline, AASM behavioral guideline, Cochrane jet-lag review). Snoring with witnessed pauses, gasping, excessive daytime sleepiness, restless legs, unusual nighttime behaviors, or persistent insomnia despite good opportunity for sleep should prompt clinical evaluation rather than more supplements (AASM OSA diagnostic guideline).
Table of contents
- Evidence summary
- Independent evidence and funding map
- What sleep problems are
- All forms and types of sleep problems
- How sleep works
- What works and what does not
- The prevention plan: sleep hygiene that actually matters
- Circadian rhythm: light, timing, exercise, caffeine, screens
- CBT-I: the first-line insomnia treatment
- Sleep apnea and other disorders not to miss
- Supplements for sleep: evidence and safety
- Risks and all side effects
- All interactions
- Who should seek medical care first
- Frequently asked questions
- Sources
Evidence summary
| Claim | Evidence | Primary source | Funding / conflict trace | Strength |
|---|---|---|---|---|
| Adults generally need at least 7 hours of sleep on a regular basis. | AASM/Sleep Research Society consensus used a modified RAND method and concluded that 7 or more hours supports adult health. | AASM/SRS consensus statement | Professional society consensus; no supplement or device sponsor in the article record. | Strong consensus |
| CBT-I is first-line for chronic insomnia. | ACP recommends CBT-I as initial treatment; AASM gives multicomponent CBT-I a strong recommendation for adults with chronic insomnia. | ACP guideline; AASM behavioral guideline | Guidelines based on systematic review methods; authors disclose relationships in full publications; no supplement-brand sponsor. | Strong |
| Face-to-face multimodal CBT-I improves sleep latency, wake after sleep onset, and sleep efficiency. | Meta-analysis of 20 RCTs and 1,162 participants found sleep-onset latency improved by about 19 minutes and wake after sleep onset by about 26 minutes. | Annals CBT-I meta-analysis | Independent academic review; no product sponsor apparent in PubMed record; trial-level blinding and comparator limitations remain. | Strong |
| Sleep hygiene alone is not an adequate treatment for chronic insomnia. | AASM suggests not using sleep hygiene as a single-component therapy for chronic insomnia. | AASM behavioral guideline | Professional guideline; no direct commercial sleep-hygiene product sponsor. | Moderate |
| Late caffeine disrupts sleep even 6 hours before bed. | 400 mg caffeine taken 0, 3, or 6 hours before bedtime significantly disrupted sleep in a randomized, double-blind, placebo-controlled study. | Drake et al., J Clin Sleep Med | Academic sleep-lab study; PubMed record does not show a caffeine-product sponsor. | Moderate |
| Exercise improves sleep quality, but timing and consistency matter. | Systematic reviews find regular exercise improves subjective sleep quality and insomnia symptoms across heterogeneous trials. | Exercise sleep meta-analysis; Review of exercise meta-analyses | Academic evidence syntheses; no single exercise-equipment sponsor drives the conclusion. | Moderate |
| Portable screen-media access/use is associated with poorer sleep outcomes, especially in children and adolescents. | Systematic review/meta-analysis found bedtime access or use was associated with inadequate sleep quantity, poor sleep quality, and excessive daytime sleepiness. | JAMA Pediatrics screen meta-analysis | Academic review; observational evidence is vulnerable to confounding by bedtime habits and family routines. | Moderate association |
| Melatonin is best for jet lag and circadian phase shift, not routine chronic adult insomnia. | Cochrane found melatonin effective for jet lag; AASM suggests not using melatonin for adult sleep-onset or sleep-maintenance insomnia. | Cochrane jet-lag review; AASM pharmacologic guideline | Cochrane review is probably independent; older trials have incomplete funding detail. AASM guideline flags limitations in drug evidence. | Works for timing; weak for insomnia |
| Sleep apnea requires diagnosis and treatment, not sleep-hygiene advice alone. | AASM recommends polysomnography or technically adequate home sleep apnea testing for uncomplicated adults at increased risk; PAP is recommended for adults with OSA and excessive sleepiness. | AASM OSA diagnostic guideline; AASM PAP guideline | Professional-society guidelines; device-industry conflicts are disclosed in guideline processes and should be checked at publication. | Strong clinical pathway |
Independent evidence and funding map
| Source | Country / scope | Evidence type | Independence rating | Credibility rank | Likely motivation |
|---|---|---|---|---|---|
| AASM behavioral insomnia guideline | United States; international literature | Clinical practice guideline using GRADE | Independent guideline; trial base varies | Very strong | Maintain professional sleep-medicine standards and reduce ineffective care. |
| ACP chronic insomnia guideline | United States; international literature | Clinical practice guideline | Probably independent | Strong | Guide primary-care decisions toward durable, lower-harm therapy. |
| CBT-I meta-analysis | International trials | Systematic review/meta-analysis | Probably independent | Strong | Academic synthesis; reputational incentive favors reproducible effect estimates. |
| Cochrane melatonin jet-lag review | International trials | Systematic review | Probably independent; older trial funding sometimes unclear | Strong | Cochrane method credibility and public evidence synthesis. |
| JAMA melatonin gummy analysis | One national retail market | Analytical chemistry quality study | Probably independent | Strong for label-accuracy risk | Consumer safety accountability; not an efficacy study. |
| Ashwagandha sleep meta-analysis | International trials, many from South Asia | Systematic review/meta-analysis | Mixed because underlying trials often involve extract manufacturers or limited disclosures | Moderate | Academic synthesis; ingredient-specific commercial incentives remain in trial base. |
| NCCIH sleep complementary approaches | United States; public-health reference | Evidence summary | Independent government health information | Strong for safety and cautious summary | Public-health education and risk reduction. |
Money and influence map: Sleep claims usually flow through four channels: professional societies and public-health agencies → clinical guidance; academic investigators → trials and meta-analyses; supplement brands → ingredient trials, gummies, blends, and marketing claims; device makers → diagnostic and treatment equipment evidence. This article gives the most weight to the first two channels and downgrades claims where product sponsors fund the only positive trials.
What sleep problems are
Sleep problems are not one condition. They can mean insufficient sleep opportunity, poor sleep timing, insomnia, breathing-related sleep disruption, movement disorders, medication effects, pain, anxiety, depression, shift-work misalignment, or a combination of these. That distinction matters because the correct fix for “I cannot sleep” may be CBT-I, a circadian timing plan, medication review, treatment for sleep apnea, pain management, mental-health care, or fewer late-day stimulants—not a stronger sedative. A useful first screen is: opportunity, timing, continuity, breathing, movement, and daytime function. If there is not enough time in bed, the first treatment is schedule protection; if sleep happens too late or too early, the target is circadian rhythm; if the problem persists despite adequate opportunity, chronic insomnia and medical sleep disorders need evaluation.All forms and grades
| Type | Typical pattern | Most useful first move | What not to do | When to escalate |
|---|---|---|---|---|
| Insufficient sleep opportunity | Too little protected sleep time because of work, caregiving, social schedule, or media use. | Set a realistic wake time and protect a sleep window that allows at least 7 hours for most adults. | Do not treat time shortage with sedatives. | Escalate if sleepiness persists despite adequate time in bed. |
| Acute insomnia | Days to weeks of trouble sleeping after stress, travel, illness, grief, or schedule disruption. | Keep wake time stable, reduce compensatory long naps, and use stimulus control early. | Do not lie awake for hours trying harder to sleep. | Escalate if symptoms approach 3 months or impair safety. |
| Chronic insomnia disorder | Difficulty initiating or maintaining sleep at least 3 nights weekly for at least 3 months, despite adequate opportunity, with daytime impairment. | CBT-I is first-line in ACP and AASM guidance (ACP guideline, AASM behavioral guideline). | Do not rely on sleep hygiene alone. | Escalate for CBT-I, medication review, and disorder screening. |
| Circadian rhythm sleep-wake disorder | Sleep is possible, but at the wrong clock time: delayed, advanced, non-24-hour, irregular, or shift-related. | Timed light, darkness, wake time, meals, activity, and sometimes timed melatonin under guidance. | Do not take melatonin randomly at bedtime if the goal is clock shifting. | Escalate if schedule impairment affects school, work, safety, or mood. |
| Obstructive sleep apnea | Snoring, pauses, choking/gasping, morning headaches, dry mouth, hypertension, or daytime sleepiness. | Sleep-medicine evaluation and diagnostic testing when risk is high (AASM OSA diagnostic guideline). | Do not mask symptoms with sedatives or alcohol. | Escalate promptly if witnessed apneas or sleepiness while driving occur. |
| Restless legs / periodic limb movements | Evening urge to move legs, crawling sensations, relief with movement, repeated leg jerks. | Assess iron status, medicines, pregnancy status, kidney disease, and sleep-medicine evaluation. | Do not assume magnesium fixes all leg symptoms. | Escalate if symptoms are frequent, painful, or disrupt bed partner sleep. |
| Parasomnias and unusual behaviors | Sleepwalking, dream enactment, violent movements, night terrors, confusion, or injuries. | Safety-proof the sleep environment and seek medical evaluation. | Do not self-treat with sedatives or alcohol. | Urgent if injury, new adult-onset dream enactment, or neurologic symptoms occur. |
Text version of this infographic
| Problem type | Pattern | Best first step |
|---|---|---|
| Not enough time | Sleep window is too short. | Protect enough time in bed; do not medicate a time shortage. |
| Wrong timing | Sleep occurs too late, too early, or irregularly. | Use timed light, consistent wake time, and properly timed melatonin when appropriate. |
| Insomnia loop | Enough opportunity but sleep effort, worry, and bed-wakefulness persist. | Use CBT-I components such as stimulus control and sleep restriction. |
| Breathing signs | Snoring, gasping, witnessed pauses, sleepiness. | Seek sleep-apnea evaluation. |
| Red flags | Sleepy driving, injuries, new dream enactment, severe daytime impairment. | Seek prompt clinical care. |
How it works
Sleep is regulated by two major forces: homeostatic sleep pressure and circadian timing. Sleep pressure builds the longer a person is awake and is partly countered by caffeine; circadian timing is controlled by the brain’s master clock and is strongly influenced by light exposure, darkness, meals, physical activity, and social schedules. The practical result is that good sleep is not just a bedtime event. Morning light, daytime activity, caffeine timing, evening light, alcohol use, stress behavior, and bed-wake conditioning all decide whether sleep arrives easily at night. AASM’s circadian guideline treats light and melatonin as timing tools, not generic sedatives (AASM circadian guideline).Text version of this infographic
Sleep pressure rises across the waking day, while the circadian clock changes alertness by time of day. Caffeine can block sleep-pressure signaling. Light can shift the circadian clock earlier or later depending on timing. Good sleep planning manages both systems: wake time, light exposure, activity, caffeine cutoff, evening dimming, and bed conditioning.
What works and what does not
| Intervention | Verdict | Evidence | Key caveat |
|---|---|---|---|
| Consistent wake time | WORKS | Core sleep-hygiene and circadian strategy; Sleep Foundation describes consistent schedule as a central sleep-hygiene behavior (Sleep Foundation). | Wake time is more powerful than bedtime because it anchors light, meals, activity, and sleep pressure. |
| Sleep hygiene alone for chronic insomnia | DOESN'T as stand-alone | AASM suggests not using sleep hygiene as a single-component chronic-insomnia treatment (AASM behavioral guideline). | Use it as the foundation, not the whole treatment. |
| CBT-I | WORKS | ACP and AASM recommend CBT-I first-line for chronic insomnia (ACP guideline, AASM behavioral guideline). | Requires behavior change; early sleep restriction can temporarily increase sleepiness. |
| Morning bright light for delayed sleep timing | WORKS when timed | AASM circadian guidance supports strategically timed light for selected circadian disorders (AASM circadian guideline). | Light at the wrong time can move the clock the wrong way. |
| Late caffeine cutoff | WORKS | 400 mg caffeine disrupted sleep when taken 6 hours before bed (Drake et al.). | Sensitive people may need a longer cutoff or lower total dose. |
| Blue-light filters alone | MIXED | Screen use affects sleep through light, time displacement, arousal, social content, and notifications; meta-analyses show association, not a single blue-light mechanism (JAMA Pediatrics meta-analysis, electronic media review). | Turning down brightness helps, but stopping stimulating content and protecting bedtime matter more. |
| Alcohol as a nightcap | DOESN'T | Alcohol may shorten sleep onset but fragments later sleep and worsens breathing risk; sleep-disorder guidance consistently discourages sedative self-treatment in suspected apnea. | Especially risky with snoring, sedatives, opioids, or sleep apnea. |
| Melatonin for jet lag / phase shift | WORKS | Cochrane found melatonin effective for preventing or reducing jet lag (Cochrane). | Timing matters more than taking a large dose. |
| Valerian as “natural Ambien” | DOESN'T | AASM suggests not using valerian for sleep-onset or sleep-maintenance insomnia (AASM pharmacologic guideline). | Possible sedation and interaction risks still exist. |
The prevention plan: sleep hygiene that actually matters
Sleep hygiene is the maintenance layer. It prevents common sleep disruption and supports CBT-I, but it usually fails when used alone for entrenched chronic insomnia. Sleep Foundation defines sleep hygiene as both the bedroom environment and sleep-related behaviors, including a strict schedule, bedtime routine, healthy habits, and a sleep-optimized bedroom (Sleep Foundation).The high-yield sleep hygiene checklist
- Protect a consistent wake time. Wake time sets the next night’s sleep pressure and circadian anchor.
- Get bright light early. Outdoor morning light is the simplest timing cue; people with eye disease, bipolar disorder, photosensitizing medicines, or migraine sensitivity should personalize this with a clinician.
- Keep naps strategic. If naps help, keep them short and earlier in the day; long late naps steal sleep pressure from bedtime.
- Use the bed for sleep and intimacy. The bed should predict sleep, not scrolling, working, arguing, or worrying.
- Stop clock-checking. Clock-checking trains threat monitoring and worsens sleep effort.
- Cool, dark, quiet, comfortable room. Environmental reviews link light, noise, heat, safety, comfort, and social environment with sleep health (physical and social sleep environment review).
- Do not compensate with long time in bed. More time in bed can worsen insomnia by increasing wakefulness in bed.
Practical insight: The most common sleep-hygiene mistake is adding relaxing habits while leaving the main disruptor untouched. If the real driver is a 6-hour sleep window, untreated apnea, a delayed circadian clock, late caffeine, or conditioned wakefulness in bed, lavender spray and a new pillow will not solve it.
Circadian rhythm: light, timing, exercise, caffeine, screens
Light timing
Light is the strongest environmental circadian cue. Morning light tends to advance the clock earlier, while bright evening and night light tends to delay the clock later. AASM’s circadian guideline supports timed light and timed melatonin for selected intrinsic circadian rhythm sleep-wake disorders, but the recommendation depends on the disorder and patient context (AASM circadian guideline).Exercise timing
Regular physical activity generally improves sleep quality and insomnia symptoms in adults, but the best timing is the timing a person can sustain. Systematic reviews of exercise and sleep find benefits across varied exercise types, intensities, and study designs, with heterogeneity in dose and outcomes (exercise meta-analysis, review of exercise meta-analyses). If vigorous late-night workouts raise body temperature and arousal, move them earlier; if evening exercise is the only sustainable option and sleep is fine, it does not need to be banned.Caffeine timing
Caffeine is a sleep-pressure blocker, not just an energy booster. In a controlled study, 400 mg caffeine taken at bedtime, 3 hours before bed, or 6 hours before bed significantly disrupted sleep, supporting a conservative cutoff at least 6 hours before intended bedtime for many adults (Drake et al.). People with anxiety, pregnancy, slow caffeine metabolism, arrhythmia concerns, or insomnia may need less caffeine and an earlier cutoff.Screen use
Screens affect sleep through several routes: bright light, content arousal, time displacement, social interaction, notifications, and bedtime procrastination. A systematic review and meta-analysis found portable screen-media device access or use was associated with inadequate sleep quantity, poor sleep quality, and excessive daytime sleepiness in children and adolescents (JAMA Pediatrics meta-analysis). A better rule than “blue light only” is: dim devices, stop interactive or emotional content before bed, remove notifications, and keep the phone out of reach if it extends wakefulness.Text version of this infographic
- Morning: wake at a consistent time, get bright light, move your body, and eat normally.
- Afternoon: finish caffeine early, exercise if possible, and keep naps short and early.
- Evening: dim lights, reduce notifications, and start a repeatable wind-down routine.
- Night: use the bed for sleep, reset if awake for a long period, keep the room dark and quiet, and avoid clock-checking.
CBT-I: the first-line insomnia treatment
CBT-I changes the behaviors and beliefs that keep insomnia alive. It is not generic sleep advice. AASM gives multicomponent CBT-I a strong recommendation for chronic insomnia disorder in adults, while ACP recommends CBT-I as the initial treatment for all adult patients with chronic insomnia disorder (AASM behavioral guideline, ACP guideline).Core CBT-I components
| Component | What it does | Example | Safety caveat |
|---|---|---|---|
| Stimulus control | Rebuilds bed = sleep association. | Go to bed only when sleepy; leave bed if awake and frustrated; return when sleepy; wake at the same time. | Modify for fall risk, disability, caregiving, or unsafe environments. |
| Sleep restriction / sleep compression | Consolidates sleep by reducing excess time awake in bed. | Temporarily match time in bed to actual sleep time, then expand gradually as sleep efficiency improves. | Needs clinician guidance for bipolar disorder, seizure disorder, high sleepiness risk, or safety-sensitive work. |
| Cognitive therapy | Reduces catastrophic beliefs and sleep effort. | Replace “I must sleep 8 hours or tomorrow is ruined” with a realistic plan for functioning after a poor night. | Not a substitute for care when severe anxiety, depression, trauma, or suicidality is present. |
| Relaxation training | Lowers arousal without forcing sleep. | Progressive muscle relaxation, paced breathing, imagery, mindfulness. | Some trauma histories need adapted relaxation methods. |
| Sleep hygiene education | Removes obvious disruptors. | Caffeine cutoff, light routine, alcohol reduction, comfortable room. | Supportive, but not enough alone for chronic insomnia. |
Text version of this infographic
CBT-I improves insomnia by combining stimulus control, sleep restriction or sleep compression, cognitive therapy, relaxation skills, and sleep hygiene education. The goal is to rebuild bed-sleep conditioning, reduce time awake in bed, lower threat thinking about sleep, and remove sleep-disrupting behaviors.
Sleep apnea and other disorders not to miss
Obstructive sleep apnea occurs when breathing repeatedly stops and restarts during sleep, which can lower oxygen and fragment sleep; NHLBI describes snoring or gasping during sleep as reasons to talk with a healthcare provider (NHLBI sleep apnea overview). AASM recommends diagnostic testing with polysomnography or technically adequate home sleep apnea testing for uncomplicated adults at increased risk, and AASM recommends positive airway pressure therapy for adults with OSA and excessive sleepiness (AASM diagnostic guideline, AASM PAP guideline).Do not self-sedate suspected apnea: Alcohol, sedatives, opioids, and some sleep supplements can worsen airway collapsibility or reduce arousal responses. If the pattern is loud snoring, witnessed pauses, gasping, morning headaches, or sleepiness while driving, the next step is evaluation, not stronger sleep aids.
Supplements for sleep: evidence and safety
Supplements can help a narrow subset of sleep problems, but the evidence is ingredient-specific and often weaker than marketing suggests. The strongest practical case is melatonin for jet lag or circadian phase shifting; the strongest behavioral treatment remains CBT-I for chronic insomnia. Magnesium, glycine, L-theanine, tart cherry, valerian/hops, and ashwagandha sit in the “may help some people, but evidence is limited or conflicted” category.| Supplement | Best-supported use | Evidence verdict | Funding/conflict note | Main safety note |
|---|---|---|---|---|
| Melatonin | Jet lag, delayed sleep-wake phase, circadian timing. | Works for timing; not first-line for chronic adult insomnia. | Cochrane probably independent; gummy label-accuracy studies not efficacy trials. | Drowsiness, headache, dizziness, nausea; caution with sedatives, anticoagulants/antiplatelets, seizure disorders, diabetes medicines, antihypertensives, immunosuppressants, pregnancy/lactation, and children unless supervised (NCCIH melatonin). |
| Magnesium | Correcting low intake/status; possibly older adults with low magnesium and insomnia. | Mixed; older-adult insomnia evidence is low to very low quality. | Small RCTs and meta-analysis; newer threonate sleep claims include industry-funded trials. | Diarrhea and GI upset; avoid unsupervised use in kidney disease; separate from tetracycline/quinolone antibiotics and bisphosphonates (NIH ODS magnesium). |
| Glycine | Subjective sleep quality and next-day fatigue in small studies using about 3 g before bed. | Promising but limited. | Many human sleep studies are small and some come from ingredient-interested research groups. | Usually GI upset or nausea at higher intakes; high-dose psychiatric use has drug-specific concerns, especially with clozapine evidence (clozapine-glycine trial). |
| Valerian / hops | Traditional herbal sleep aid. | Weak / not recommended for chronic insomnia. | Systematic reviews show inconsistent results; products vary by extract and dose. | Headache, stomach upset, mental dullness, vivid dreams; avoid combining with alcohol or sedatives (NCCIH valerian). |
| Tart cherry | Small insomnia trials; possible melatonin/tryptophan pathway. | Limited. | Early pilot trials used proprietary juice products or small samples. | GI symptoms and sugar load may matter; interaction evidence is sparse, so caution with anticoagulants or diabetes management is prudent. |
| L-theanine | Stress-related arousal and calm focus; sleep effects indirect. | Mixed. | Several positive trials use branded ingredients or industry funding; independent replication is limited. | Generally tolerated short-term; possible headache/GI effects; caution with sedatives, antihypertensives, stimulants, and high-caffeine stacks. |
| Ashwagandha | Stress-related sleep complaints in some trials. | Moderate-low; conflict-sensitive. | Meta-analysis positive, but many trials involve branded extracts or incomplete funding transparency (ashwagandha sleep meta-analysis). | Drowsiness, stomach upset, diarrhea, vomiting, rare liver injury; avoid in pregnancy and use caution with thyroid disease, autoimmune disease, sedatives, and liver disease (NCCIH ashwagandha, LiverTox). |
Text version of this infographic
- Strongest practical evidence: melatonin for jet lag and circadian phase shift.
- Limited but plausible: magnesium when intake/status is low, glycine, L-theanine for arousal, and tart cherry in small trials.
- Conflict-sensitive: ashwagandha extracts and branded sleep blends, where product sponsors often appear in the trial base.
- Weak: valerian as a “natural Ambien,” homeopathic sleep remedies, and large proprietary gummy blends.
Risks and all side effects
| Intervention / supplement | Common side effects or harms | Rare but serious concerns | At-risk groups | Source |
|---|---|---|---|---|
| CBT-I sleep restriction | Temporary sleepiness, irritability, fatigue during early consolidation. | Sleepiness-related accidents if applied aggressively. | Safety-sensitive workers, seizure disorder, bipolar disorder, high fall risk, uncontrolled severe sleepiness. | AASM behavioral guideline |
| Bright light | Eye strain, headache, agitation in sensitive people. | Mania/hypomania trigger in susceptible people; retinal concerns in eye disease require supervision. | Bipolar disorder, migraine, retinal disease, photosensitizing medicines. | AASM circadian guideline |
| Caffeine | Insomnia, anxiety, palpitations, reflux, tremor, diuresis. | Arrhythmia or severe anxiety in susceptible people; withdrawal headaches. | Insomnia, anxiety disorders, pregnancy/lactation, arrhythmia, hypertension sensitivity. | Drake et al. |
| Melatonin | Daytime sleepiness, headache, dizziness, nausea, vivid dreams. | Worsened mood or seizure concerns in susceptible people; uncertain long-term pediatric endocrine effects. | Children, pregnancy/lactation, seizure disorders, autoimmune disease, people taking interacting medicines. | NCCIH melatonin |
| Magnesium | Diarrhea, nausea, abdominal cramping. | Hypermagnesemia with low blood pressure, confusion, arrhythmia, respiratory depression, especially in kidney impairment. | Kidney disease, older adults with reduced kidney function, people using multiple magnesium-containing products. | NIH ODS magnesium |
| Valerian / hops | Headache, stomach upset, mental dullness, excitability, uneasiness, vivid dreams. | Excess sedation; rare liver-injury case reports are difficult to attribute because products are often multi-ingredient. | Pregnancy/lactation, liver disease, sedative users, alcohol use. | NCCIH valerian |
| Ashwagandha | Drowsiness, stomach upset, diarrhea, vomiting. | Rare clinically apparent liver injury; thyroid hormone effects; miscarriage concern. | Pregnancy, liver disease, thyroid disease, autoimmune disease, sedative users. | NCCIH ashwagandha; LiverTox |
| CBD/cannabinoid sleep products | Fatigue, GI discomfort, appetite changes, diarrhea, drowsiness. | Liver enzyme elevations and drug interactions via metabolism pathways. | Liver disease, pregnancy/lactation, sedative users, people taking narrow-therapeutic-index drugs. | StatPearls CBD; CBD liver-toxicity review |
All interactions
| Interacts with | Type | Severity | Mechanism | Action |
|---|---|---|---|---|
| Melatonin × sedatives, alcohol, opioids, benzodiazepines, Z-drugs | Additive sedation | Avoid or medical supervision | Combined CNS-depressant effects can impair coordination, breathing-risk awareness, and next-day function. | Do not combine for self-treatment; avoid driving if sedated. |
| Melatonin × anticoagulants/antiplatelets | Possible bleeding-risk change | Caution | Interaction reports are limited but plausible enough for supervision. | Ask a clinician before use if taking warfarin, DOACs, aspirin, or clopidogrel. |
| Melatonin × diabetes medicines / blood pressure medicines | Metabolic or blood-pressure effect | Monitor | Melatonin may affect glucose and blood pressure regulation in some contexts. | Use clinician guidance when glucose or BP targets are medically managed. |
| Magnesium × tetracycline or quinolone antibiotics | Reduced drug absorption | Separate doses | Magnesium binds antibiotics in the gut and can reduce absorption. | Separate by the medication label’s instructed interval. |
| Magnesium × bisphosphonates | Reduced drug absorption | Separate doses | Minerals can bind the medicine and reduce absorption. | Take bisphosphonate exactly as prescribed; keep minerals away from that dosing window. |
| Magnesium × diuretics / PPIs | Magnesium balance changes | Monitor | Some diuretics increase magnesium loss; chronic PPI use is linked to low magnesium in susceptible users. | Discuss testing if long-term use or symptoms of deficiency occur (NIH ODS magnesium). |
| Valerian/hops × alcohol, sedatives, antihistamines, opioids | Additive sedation | Avoid | Potential sleep-inducing and CNS-depressant effects may stack. | Do not combine unless a clinician explicitly approves (NCCIH valerian). |
| Ashwagandha × sedatives | Additive sedation | Caution | Drowsiness is a known adverse effect. | Avoid mixing with other sedating agents. |
| Ashwagandha × thyroid medicines / thyroid disease | Possible thyroid hormone effect | Medical supervision | NCCIH notes thyroid-related concerns. | Do not self-prescribe if thyroid status is medically managed. |
| CBD × sedatives, alcohol, anticonvulsants, anticoagulants, antidepressants, immunosuppressants | Drug-metabolism and additive-sedation risk | Medical supervision | CBD can affect liver enzymes and sedation; hepatotoxicity risk increases with some medicines. | Avoid casual sleep use when taking prescription medicines with narrow safety margins. |
Who should seek medical care first
Seek evaluation before trying more sleep aids if any of these apply: witnessed breathing pauses, choking or gasping during sleep, sleepiness while driving, new violent dream enactment, fainting or chest pain at night, severe depression or suicidal thoughts, pregnancy, seizures, bipolar disorder, chronic opioid or sedative use, chronic lung or heart disease, neurologic disease, significant weight change with snoring, or insomnia that persists at least 3 months despite adequate sleep opportunity.Frequently asked questions
What is the fastest evidence-based way to fix insomnia?
The fastest sustainable path is not usually a supplement; it is identifying the insomnia driver and starting CBT-I principles early. ACP and AASM recommend CBT-I as first-line therapy for chronic insomnia because it changes the learned sleep-wake patterns that keep insomnia going (ACP guideline, AASM behavioral guideline).
Is sleep hygiene enough for chronic insomnia?
No. Sleep hygiene is useful as a foundation, but AASM suggests not using sleep hygiene as a single-component treatment for chronic insomnia (AASM behavioral guideline).
Does melatonin help sleep?
Melatonin helps most when the problem is timing, such as jet lag or delayed sleep-wake phase, but it is not recommended as a routine stand-alone treatment for chronic adult insomnia by AASM (Cochrane jet-lag review, AASM pharmacologic guideline).
How late is too late for caffeine?
A controlled study found that 400 mg caffeine disrupted sleep even when taken 6 hours before bedtime, so a 6-hour cutoff is a reasonable minimum for many adults (Drake et al.). Sensitive people may need a longer cutoff.
Are screens bad because of blue light only?
No. Blue light is one mechanism, but screens also delay bedtime, increase mental arousal, deliver notifications, and encourage social or emotional engagement. Meta-analyses link screen-media use with poorer sleep outcomes, especially in youth, but the fix is behavioral as well as optical (JAMA Pediatrics meta-analysis).
What are signs that it might be sleep apnea?
Loud snoring, witnessed pauses, choking or gasping during sleep, morning headaches, dry mouth, high blood pressure, and daytime sleepiness are common warning signs. AASM recommends diagnostic testing for adults at increased risk rather than treating suspected apnea as simple insomnia (AASM OSA diagnostic guideline).
Is magnesium a good sleep supplement?
Magnesium may help if intake or status is low, but insomnia evidence is limited and low quality. NIH notes magnesium safety and interaction concerns, especially diarrhea, kidney disease risk, and interactions with antibiotics and bisphosphonates (NIH ODS magnesium).
Can exercise close to bedtime ruin sleep?
Regular exercise generally supports better sleep, but individual timing matters. If vigorous late exercise causes alertness or heat that delays sleep, move it earlier; if it does not disrupt sleep and is the only sustainable time, a blanket ban is unnecessary (exercise sleep meta-analysis).
Sources
- AASM/SRS. Recommended Amount of Sleep for a Healthy Adult. PMC
- Qaseem A, et al. Management of Chronic Insomnia Disorder in Adults: ACP Guideline. PubMed
- Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: AASM guideline. PMC
- Trauer JM, et al. CBT-I for chronic insomnia: systematic review and meta-analysis. PubMed
- Sateia MJ, et al. AASM pharmacologic treatment guideline for chronic insomnia. PubMed
- Herxheimer A, Petrie KJ. Melatonin for jet lag. Cochrane
- Auger RR, et al. AASM circadian rhythm sleep-wake disorders guideline. PMC
- Kapur VK, et al. AASM diagnostic testing guideline for adult OSA. PubMed
- Patil SP, et al. AASM PAP treatment guideline for adult OSA. PubMed
- Drake C, et al. Caffeine effects on sleep taken 0, 3, or 6 hours before bed. PubMed
- Kredlow MA, et al. Exercise and sleep review. PMC
- Xie Y, et al. Exercise effects on sleep quality and insomnia. PMC
- Carter B, et al. Portable screen-based media device use and sleep outcomes. PMC
- Billings ME, et al. Physical and social environment relationship with sleep. PMC
- NCCIH. Sleep Disorders and Complementary Health Approaches. NCCIH
- NCCIH. Melatonin: What You Need To Know. NCCIH
- NIH Office of Dietary Supplements. Magnesium Fact Sheet. NIH ODS
- NCCIH. Valerian: Usefulness and Safety. NCCIH
- NCCIH. Ashwagandha. NCCIH
- LiverTox. Ashwagandha. NCBI Bookshelf
- Sleep Foundation. Sleep Hygiene. Sleep Foundation